Press "Enter" to skip to content

New patent for Ibsa Inst drug LICART

0
Copyright © DrugPatentWatch. Originally published at New patent for Ibsa Inst drug LICART

Annual Drug Patent Expirations for LICART
Annual Drug Patent Expirations for LICART

Licart is a drug marketed by Ibsa Inst Bio and is included in one NDA.

The generic ingredient in LICART is diclofenac epolamine. Additional details are available on the diclofenac epolamine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Ibsa Inst drug LICART
Find your next blockbuster

Get accurate and timely intelligence — in just a few clicks

✓ Free trial

✓ No credit card

 

DrugPatentWatch - Make Better Decisions